Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?
- PMID: 30870838
- DOI: 10.1159/000495839
Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?
Comment in
-
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.Gerontology. 2019;65(4):385-386. doi: 10.1159/000496469. Epub 2019 Mar 1. Gerontology. 2019. PMID: 30820018 No abstract available.
Comment on
-
Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention.Gerontology. 2019;65(3):229-239. doi: 10.1159/000494137. Epub 2018 Nov 21. Gerontology. 2019. PMID: 30463070 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
